Global Large Molecule Bioanalytical Technologies Market Research Report 2021 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Large Molecule Bioanalytical Technologies Market Size, Share & Trends Analysis Report by Product, by Technology (Chromatography, Electrophoresis), by Application, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global large molecule bioanalytical technologies market size is expected to reach USD 13.9 billion by 2028 and is estimated to expand at a CAGR of 13.5% from 2021 to 2028

The demand for bioanalytical testing services has significantly increased over the past few years, thereby positively impacting the growth of the market.

This is primarily due to the growing R&D activities in the biopharmaceutical industry, leading to notable investments in the space. Also, the ongoing pandemic of COVID-19 has resulted in the expansion of manufacturing and R&D capabilities of key stakeholders leading to increased demand for bioanalytical testing services. The use of advanced technologies in vaccine and cell gene therapy development has led to significant growth of this space.

Advancements in instrumentation have created lucrative opportunities for contract manufacturers. Over the past several years, biopharmaceutical manufacturers are outsourcing at least some part of their biomanufacturing activities.

Analytical testing is one of the most outsourced activities as it requires highly specialized personnel and equipment to conduct assays. These factors are anticipated to play a vital role in shaping market growth.

Large Molecule Bioanalytical Technologies Market Report Highlights

• The product segment accounted for the largest revenue share in 2020
• Biopharmaceutical products require various instruments for characterization, identification, purity, and potency testing
• Availability of a wide range of products for the aforementioned assay applications is the key factor contributing to segment growth
• Mass spectrometry captured the maximum revenue share in 2020 due to the diversification of products as well as their frequent usage
• This technology has been conventionally used in the development of protein pharmaceuticals, for instance, in the analysis of confirmations of amino acids in proteins
• Furthermore, quantitative PCR (qPCR) is widely adopted in the detection of viral contaminants during the manufacture of biopharmaceuticals
• Thus, with the growing demand for viral vectors, this technology is anticipated to witness the fastest growth over the forecast period
• Moreover, the presence of a wide array of products in spectrometry is one of the key industry factors driving investment in the segment
• Biologics accounted for the major revenue share in 2020 owing to the ever-expanding R&D activity programs in the segment
• Besides, the presence of a stringent regulatory framework for advanced therapies has increased the demand for bioanalytical testing services
• The COVID-19 pandemic has accelerated the development of genetic vaccines
• This increases the utility of analytical tools for assessing the safety and stability of large molecules, thereby driving the segment
• North America dominated the market in 2020 owing to the presence of strong research as well as a commercial base for biopharmaceutical manufacturing
• Moreover, the U.S. is the largest biopharmaceutical market that has positively influenced the adoption and usage of large molecule bioanalytical technologies in the region
• In the Asia Pacific, the market is estimated to register the fastest CAGR with emerging markets such as China and Japan at the forefront
• Collaborations between domestic and global players for expansion of biomanufacturing capabilities are supplementing the growth of the market in the region
• Key companies are focusing on new product launches to sustain their position in the market

Market Dynamics

Market driver Analysis

• Technological advancements in life science tools and analytical instruments
• Rising collaboration between operating stakeholders
• Rising advancements, automation, and expansion in laboratory facilities

Market Restraint Analysis

• Timeline, speed & cost-related challenges
• Complicated bioanalytical assays due to complex nature of large molecules
• Challenges associated with sample preparation

Market Opportunity Analysis

• Vaccine development against SARS-CoV-2 infection
• Commercial success of biopharmaceuticals and consequent increase in demand for biopharmaceuticals
• Notable growth of biologics & biosimilars

Market threat Analysis

• Dominance of small molecule

COVID-19 Impact analysis

• Short-term impact
• Long-term impact
• Challenge Analysis
• Opportunity Analysis
• Key developments & activities

Penetration & Growth Prospect Mapping for Therapeutic Applications, 2020

Porter's Analysis

COVID-19 Impact Analysis

Technology Business Analysis

• Chromatography
• Mass Spectrometry
• Western Blot
• ddPCR, qPCR, RT-PCR
• ELISA
• Flow Cytometry
• Spectrometer
• UV/Vis
• CD
• Raman
• Laser-induced breakdown spectroscopy
• Analytical ultracentrifugation
• Light scattering (MALS, DLS) & static light scattering
• DNA Sequencing

Competitive Analysis

• Intertek Group plc.
• SOLVIAS AG
• Bio-Techne Corporation
• Wyatt Technology Corporation
• Precision NanoSystems
• Verder
• Halo Labs
• Charles River Laboratories International, Inc.
• Avomeen
• Merck KGaA
• Cergentis B.V.
• Laboratory Corporation of America Holdings
• DH Tech. Dev. Pte. Ltd. (SCIEX)
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/dji8cj